CALGARY, Sept. 6, 2018 /CNW/ – Pond Technologies Holdings Inc. (TSX.V: POND) is pleased to announce that Grant Smith, President of RFI Canada Ltd., has joined Pond Technologies as a Strategic Advisor for Pond’s nutraceutical, sustainable protein and ingredient vertical. Mr. Smith will be advising Pond on the recently proposed Regenurex acquisition and integration.
Grant Smith is a 25-year veteran of the North American nutraceutical industry. As President of RFI Canada, Grant has served as a valued ingredient and formulation advisor to some of North America’s leading nutraceutical, food and beverage companies.
Grant Smith commented, “This is a great opportunity for both Pond and Regenurex in that their upstream and downstream technologies are complimentary. Pond’s proprietary growth platform should bring efficiency and scale to Regenurex operations and Regenurex’s unique all-natural extraction technology is expected to provide a competitive edge for the combined entity in this expanding market”.
“Astaxanthin is used extensively in aquaculture to reduce the incidence of disease and it also happens to be the key ingredient that turns salmon pink. Over the last 10 years, Astaxanthin has seen substantial growth as a health food supplement. It has been called the world’s most powerful anti-oxidant and been positively linked in various studies to the improvement of muscle recovery, joint, eye, brain, heart and skin health.” Smith explained. “I am excited to help Pond and Regenurex capture market share in this billion-dollar ingredient which is projected to continue growing at more than 20% annually over the next several years”.
About Pond Technologies:
Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of pollution abatement and nutrition. Pond’s proprietary growth platform optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. It enables industrial emitters to generate new revenue streams from the transformation of waste CO2 to valuable algae-based products used as proteins for animal feed and nutraceutical products like Chlorella, Spirulina and Astaxanthin for human consumption.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.
Media Contact: Sandra Martin | email@example.com | +1 (416) 399-4153
Investor Relations: Chris Cory | firstname.lastname@example.org | +1 (416) 616-0866